Suppr超能文献

肝移植患者模式识别受体反应性筛查:实现个性化和精准器官匹配以降低缺血再灌注损伤风险的潜力。

Pattern Recognition Receptor-reactivity Screening of Liver Transplant Patients: Potential for Personalized and Precise Organ Matching to Reduce Risks of Ischemia-reperfusion Injury.

机构信息

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA.

Division of Liver and Pancreas Transplantation, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA.

出版信息

Ann Surg. 2020 May;271(5):922-931. doi: 10.1097/SLA.0000000000003085.

Abstract

OBJECTIVE AND BACKGROUND

Pattern recognition receptors (PRRs) on immune and parenchymal cells can detect danger-associated molecular patterns (DAMPs) released from cells damaged during ischemia-reperfusion injury (IRI), in heart attack or stroke settings, but also as an unavoidable consequence of solid organ transplantation. Despite IRI being a significant clinical problem across all solid organ transplants, there are limited therapeutics and patient-specific diagnostics currently available.

METHODS

We screened portal blood samples obtained from 67 human liver transplant recipients both pre- [portal vein (PV) sample] and post-(liver flush; LF) reperfusion for their ability to activate a panel of PRRs, and analyzed this reactivity in relation to biopsy-proven IRI.

RESULTS

PV samples from IRI+ orthotopic liver transplantation (OLT) patients (n = 35) decreased activation of hTLR4- and hTLR9-transfected cells, whereas PV from IRI- patients (n = 32) primarily increased hTLR7 and hNOD2 activation. LF samples from OLT-IRI patients significantly increased activation of hTLR4 and hTLR9 over IRI- LF. In addition, the change from baseline reactivity to hTLR4/9/NOD2 was significantly higher in IRI+ than IRI- OLT patients.

CONCLUSIONS

These results demonstrate that TLR4/7/9 and NOD2 are involved in either promoting or attenuating hepatic IRI, and suggest a diagnostic screening of portal blood for reactivity to these PRRs might prove useful for prediction and/or therapeutic intervention in OLT patients before transplantation.

摘要

目的和背景

免疫细胞和实质细胞上的模式识别受体(PRRs)可以检测到在缺血再灌注损伤(IRI)、心脏病发作或中风情况下受损细胞释放的危险相关分子模式(DAMPs),但也作为实体器官移植不可避免的后果。尽管 IRI 是所有实体器官移植中一个重要的临床问题,但目前可用的治疗方法和针对患者的诊断方法有限。

方法

我们对 67 名接受肝移植的患者的门静脉血样进行了筛查,这些血样分别在再灌注前(门静脉样本)和再灌注后(肝脏冲洗;LF)获得,以检测其激活一组 PRRs 的能力,并分析这种反应与活检证实的 IRI 之间的关系。

结果

来自 IRI+原位肝移植(OLT)患者(n=35)的 PV 样本降低了 hTLR4 和 hTLR9 转染细胞的激活,而来自 IRI-患者(n=32)的 PV 样本主要增加了 hTLR7 和 hNOD2 的激活。OLT-IRI 患者的 LF 样本显著增加了 hTLR4 和 hTLR9 的激活,超过了 IRI-LF。此外,与 IRI-OLT 患者相比,IRI+OLT 患者的 hTLR4/9/NOD2 基线反应性的变化显著更高。

结论

这些结果表明,TLR4/7/9 和 NOD2 参与促进或减轻肝 IRI,并且提示对门静脉血中这些 PRRs 的反应进行筛查可能有助于在移植前预测和/或干预 OLT 患者。

相似文献

引用本文的文献

5
New therapeutic concepts against ischemia-reperfusion injury in organ transplantation.器官移植中对抗缺血再灌注损伤的新治疗概念。
Expert Rev Clin Immunol. 2023 Jul-Dec;19(10):1205-1224. doi: 10.1080/1744666X.2023.2240516. Epub 2023 Jul 28.
8
Liver ischaemia-reperfusion injury: a new understanding of the role of innate immunity.肝脏缺血再灌注损伤:固有免疫作用的新认识。
Nat Rev Gastroenterol Hepatol. 2022 Apr;19(4):239-256. doi: 10.1038/s41575-021-00549-8. Epub 2021 Nov 26.

本文引用的文献

1
Normothermic machine perfusion of the liver.肝脏常温机器灌注
Clin Liver Dis (Hoboken). 2017 Oct 31;10(4):97-99. doi: 10.1002/cld.661. eCollection 2017 Oct.
5
Portal-vein blood samples as a new diagnostic entity for pancreatic cancer.门静脉血样本作为胰腺癌的一种新的诊断实体。
Expert Rev Gastroenterol Hepatol. 2016 Jun;10(6):665-7. doi: 10.1080/17474124.2016.1176911. Epub 2016 May 3.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验